Decision aid development and its acceptability among adults with attention‐deficit/hyperactivity disorders regarding treatment discontinuation after remission-Reference-Cited by-同舟云学术

Decision aid development and its acceptability among adults with attention‐deficit/hyperactivity disorders regarding treatment discontinuation after remission

Published:2022-11-14 Issue:4 Volume:1 Page:
ISSN:2769-2558
Container-title:Psychiatry and Clinical Neurosciences Reports
language:en
Short-container-title:PCN Reports

Author:

Tsujii Noa¹²,Okada Takashi³,Usami Masahide⁴^ORCID,Kuwabara Hidenori⁵,Fujita Junichi⁶,Negoro Hideki⁷,Iida Junzo⁸,Aoki Yumi⁹,Takaesu Yoshikazu¹⁰,Saito Takuya¹¹

Affiliation:

1. Department of Child Mental Health and Development Toyama University Hospital Toyama Toyama Japan

2. Department of Neuropsychiatry Kindai University Faculty of Medicine Osakasayama Osaka Japan

3. Department of Developmental Disorders, National Institute of Mental Health National Center of Neurology and Psychiatry Kodaira Tokyo Japan

4. Department of Child and Adolescent Psychiatry, Kohnodai Hospital National Center for Global Health and Medicine Ichikawa Chiba Japan

5. Senogawa Hospital Hiroshima‐shi Hiroshima Japan

6. Department of Child Psychiatry Yokohama City University Hospital Yokohama Kanagawa Japan

7. Shigisan Hospital Herarland Shigisan Ikoma Nara Japan

8. Medical Corporation Nanfukai Manyo Clinic Child Mental Health Care Center Kizuna Kashihara Nara Japan

9. Graduate School of Nursing St. Luke's International University Chuo‐ku Tokyo Japan

10. Department of Neuropsychiatry, Graduate School of Medicine University of the Ryukyus Okinawa Japan

11. Department of Child and Adolescent Psychiatry, Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pcn5.57

Reference32 articles.

1. Diagnostic and Statistical Manual of Mental Disorders

2. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder

3. Attention-deficit/hyperactivity disorder

4. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder

5. Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder